1Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome:a new dilemma[J], J Thorae Cardiovase Surg, 1994,107(3) : 942.
2Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open heart surgery[J]. Cardiovase Surg, 1998,39:619.
3Argenziano M,Chen JM,Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent [J]. J Thorac Cardiovasc Surg, 1998,116 (6) : 973.
5Witthaut R. Science review:natriuretic peptides in critical illness[J]. Crit Care, 2004,8 (5) : 342.
6Kerbaul F,Collart F, Giorgi R, et al. Role of endogenous adenosine as a predictive marker of vasoplegia during cardlopulmonary bypass and postoperative severe systemic inflammatory response[J]. Crit Care Med, 2006,34 (3) : 640.
8Mekontso-Dessap A, Houel R,Soustelle C,et al. Risk factors for postcardiopulmonary bypass vasoplegia in patients with preserved left ventricular function[J]. Ann Thorac Surg,2001,71(5) : 1428.
9Cremer J, Martin M,Redl H, et al. Systemic inflammatory response syndrome after cardiac operations[J]. Ann Thorac Surg, 1996,61(6) : 1714.
10Conti VR,McQuitty C. Vasodilation and cardiopulmonary bypass : the role of bradykinin and the pulmonary vascular endothelium[J]. Chest,2001,120(6) : 1759.
二级参考文献21
1[1]Gomes WJ,Carvalho AC,Palma JH,et al.Vasoplegic syndrome after open heart surgery [J].J Cardiovasc Surg (Torino),1998,39:619 -623.
2[2]Kristof AS,Magder S.Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass[J].Crit Care Med,1999,27:1121 - 1127.
3[3]Mekontso - Dessap A,Houel R,Soustelle C,et al.Risk factors for post - cardiopulmonary bypass vasoplegia in patients with pieserved left ventricular function[J].Ann Thorac Surg,2001,71:1428 - 1432.
4[4]Vila E,Salaices M.Cytokines and vascular reactivity in resistance arteries[J].Am J Physiol Heart Circ Physiol,2005,288:1016 - 1021.
6[6]Ordonez FA,Hernandez FA,Borrego DJM,et al.The systemic vasodilatory action of protamine:is it inhibited or mediated by heparin[J] ? Res Exp Med (Berl) ,1998,197:337 - 347.
7[7]Gomes WJ,Erlichman M R,Batista - Filho M L,et al.Vasoplegic syndrome after off - pump coronary artery bypass surgery[J].Eur J Cardiothorac Surg,2003 ,23 :165 - 169.
8[8]Levin RL,Degrange MA,Bruno GF,et al.Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery[J].Ann Thorac Surg,2004,77:496 -499.
9[9]Dunser MW,Wenzel V,Mayr AJ,et al.Management of vasodilatory shock:defining the role of arginine vasopressin [J].Drugs,2003,63:237 -256.
10Hansen TN, Dawson PE, Brockbank KGM. Effects of hypothermia upon endothelium cells: mechanisms and clinical importance. Cryobiology, 1994,31:101-106.
5Dimser MW,Westphal M.Arginine vasopressin in vasodilatory shock:effects on metabolism and beyond [J].Curr Opin Anaesthesiol, 2008,21 (2) : 122.
6Levin RL,Degrange MA,Bruno GF. Methylene blue reduces mortality and morbidity in vasoplegic patients af-ter cardiac surgery[J].{H}ANNALS OF THORACIC SURGERY,2004,(2):496-499.
7Levin MA,Lin HM,Castillo JG. Early on-cardiopul-monary bypass hypotension and other factors associated with vasoplegic syndrome[J].{H}CIRCULATION,2009,(17):1664-1671.
8Byrne JG,Leacche M,Paul S. Risk factors and out-comes for "vasoplegia syndrome” following cardiac trans-plantation[J].{H}European Journal of Cardio-thoracic Surgery,2004,(3):327-332.
9Armand MD,Remi H,Celine S. Rsik factors after post-cardiopulmonary bypass vasplegia in patients with preserved left ventricular function[J].{H}ANNALS OF THORACIC SURGERY,2001,(5):1428-1432.
10Edmunds LH Jr. Inflammatory response to cardiopulmo-nary bypass[J].{H}ANNALS OF THORACIC SURGERY,1998,(Suppl 5):S12.
